Learn more about UC TechAlerts – Subscribe to categories and get notified of new UC technologies

Browse Category: Medical > Disease: Ophthalmology and Optometry

Categories

[Search within category]

Docking System To Stabilize Eyeball During Intraocular Surgery

UCLA researchers in the Department of Mechanical Engineering have designed a docking system to secure the eyeball relative to the imaging-system probe, allowing for the use of surgical instruments or tools, and facilitate real-time image acquisition during intraocular surgery.

Rapid And Precise Tool Exchange Mechanism For Intraocular Robotic Surgical Systems

UCLA researchers from the Department of Mechanical Engineering have developed a rapid, precise, and repeatable tool exchange mechanism for intraocular surgical procedures. This mechanism reduces surgery time, undesirable surgical tool movements, complications, and recovery time.

Intraoperative Assessment Of Implant Positioning

Researchers from the Departments of Mechanical Engineering and Ophthalmology led by Dr. Jean-Pierre Hubschman have developed a modified intralocular lens (IOL) and surgical implantation procedure to treat cataract and refractive anomalies.

Methods And Systems For Vision Enhancement And Rehabilitation For Hemianopic Visual Loss

Researchers led by Navid Amini from the Department of Ophthalmology at UCLA have developed a novel device that can compensate for neurological vision loss, such as the vision loss after stroke.

Vaccine Against Herpes Simplex Virus Infection

Herpes simplex virus (HSV) infections affect billions of patients worldwide and can manifest its symptoms as painful blisters or ulcers at oral, ocular or genital locations. Symptomatic patients can currently only alleviate their pains with antiviral medication. This technology proposes a shift in focus toward novel protective epitopes as the foundation for new vaccines.

Novel Therapy for Treating Fungal Infection of the Cornea

Fungal keratitis is an infection of the cornea caused by pathogenic fungi that is challenging to treat. This therapy is a novel topical application of a commercially-available malarial drug to treat fungal keratitis with fewer side effects than current treatments.

Stem Cell-Derived Exosomes for the Treatment of Corneal Scarring

UCLA researchers in the Department of Ophthalmology have developed a novel method to heal corneal scarring using exosomes from immortalized corneal stem cells.

Safe Vector for Glaucoma Gene Therapy

UCLA researchers from the Department of Ophthalmology have developed a novel gene therapy approach to cure eye diseases such as glaucoma using naked plasmid DNA.

Method for creating a macular/retinal degeneration animal model

Researchers at UCI have developed an animal model that mimics the onset and progression of age-related macular degeneration, an incurable disease that is the fourth-leading cause of blindness globally. The model serves as a means for testing the efficacy of possible treatments and cures.

Anti-Microbial Contact Lens With Ocular Drug Delivery

Anti-microbial, anti-fungal drug eluting contact lens for the controlled release of ophthalmic therapeutics.

Novel Anti-Bacterial, Anti-Fungal Nanopillared Surface

Medical devices are susceptible to contamination by harmful microbes, such as bacteria and fungi, which form biofilms on device surfaces. These biofilms are often resistant to antibiotics and other current treatments, resulting in over 2 million people per year suffering from diseases related to these contaminating microbes. Death rates for many of these diseases are high, often exceeding 50%. Researchers at UCI have developed a novel anti-bacterial and anti-fungal biocomposite that incorporates a nanopillared surface structure that can be applied as a coating to medical devices.

Nonlinear Optical Photodynamic Therapy of the Cornea for Corneal Disorders, Cancer, and Infection

Inventors at UC Irvine have developed an apparatus and method using nonlinear optical photodynamic therapy (NLO-PDT) for modifying corneal shape and treating progressive corneal astigmatism and refractive errors. The selectively focused femtosecond-near infrared laser light and apparatus improves upon existing methods by providing rapid (< 1min) corneal treatment that minimizes unwanted cellular damage to the eye through precise lateral and axial treatment to the cornea.

Novel Surgical Device for Scleral Buckling Retinal Detachment Repair

UCLA researchers in the Departments of Ophthalmology and Engineering have developed a new surgical device used in retinal detachment surgery.

Sieve Container For Contactless Media Exchange For Cell Growth

Media that contains nutrients and growth factors is necessary to grow all types of cells, a process that is widely used in many fields of research. Such media should be routinely changed either to different media or a fresh batch of the same media. This change currently involves either using a pipette to transfer cells from their current dish of media to a new dish, or aspirating the media out of the dish and replacing it with new media. Both methods have inherent risks to stressing and damaging the cells. Researchers at UCI have developed a unique dish for growing cells that allows for safer aspiration of the old media, which reduces stress and damage to the cells.

Scanning Method For Uniform, Normal-Incidence Imaging Of Spherical Surface With A Single Beam

UCLA researchers have created a method that achieves uniform normal-incident illumination of a spherical surface by first projecting the sphere onto a Cartesian plane and then raster scanning it using an illuminating beam. This allows the scanned object, the illumination source, and the detector to remain stationary.

Xenobiotic-Free Culture System To Expand Human Limbal Stem Cells

UCLA researchers in the Departments of Opthalmology have developed a xenobiotic-free manufacturing process to produce transplantable human limbal stem cells for use in treating limbal stem cell deficiency.

A Method for Induction of Corneal Endothelial Cells from Human Pluripotent Stem Cells (PSCs) via Ocular Lineage Specification

One of the most common causes of loss of vision is by corneal endothelial dystrophy (CED). Moreover, Fuchs CED is the leading cause of age-related blindness in individuals over the age of 40 in the United States affecting ~ 4% of the population. The current standard of care is to perform restorative corneal transplantation, but due to a shortage of healthy human donors, this is a challenge confronting the medical community. One solution would be to develop alternative sources of transplantation material. Human corneal endothelial cells (CESs) are not proliferative and do not regenerate in vivo. Therefore, there is a major interest in development of in vitro expandable cell sources for engineering corneal endothelium.

Wireless Implantable System To Restore Memory

UCLA researchers have developed a wireless implantable deep brain stimulation system to restore memory in individuals with traumatic brain injury.

Intraocular Pressure measuring device

The present invention discloses a small device to measure Intraocular Pressure. This invention communicating the measurements of Intraocular pressure with outside devices.

Artificial cornea implant using nanopatterned synthetic polymer

Corneal blindness accounts for 50% of blindness in developing countries and artificial corneas need in scenarios in which a donor cornea is unusable or unavailable. Artificial corneas suffer from a myriad of problems ranging from mechanically weak corneas at junction sites to the necessity of lifetime antibiotic administration for the patient. This technology is a one piece artificial cornea that is biocompatible, durable and naturally antimicrobial/antibacterial.

Potent And Highly Soluble Pegylated Compstatin Peptide

UCR researchers have developed novel compstatin peptides with polar amino acid extensions at the N-terminus and PEGylated extensions at the C-terminus. The new peptides have the following advantages compared to previously known compstatin peptides: (i) highly improved aqueous solubility while maintaining high inhibitory potency, and (ii) higher inhibitory efficacy against complement system activation in a human retinal pigmented epithelial cell-based assay that mimics the pathobiology of age-related macular degeneration. The combined solubility and inhibitory potency and efficacy properties render the new peptides excellent candidates to become therapeutics for the treatment of age-related macular degeneration.   A potent and highly soluble compstatin peptide shown in surface representation with an 8 PEG block C-terminal extension displayed in stick form. The surface of the compstatin analog is colored according to amino acid properties: gray for hydrophobic, green for polar neutral, blue for polar positively charged, red for polar negatively charged, yellow for cysteines of the disulfide bridge, and brown for glycine. The molecular image is generated using three-dimensional coordinates from a molecular dynamics simulation trajectory.    

A Micro/Nanobubble Oxygenated Solutions for Wound Healing and Tissue Preservation

Soft-tissue injuries and organ transplantation are common in modern combat scenarios. Organs and tissues harvested for transplantation need to be preserved during transport, which can be very difficult. Micro and nanobubbles (MNBs) offer a new technology that could supply oxygenation to such tissues prior to transplantation, thus affording better recovery and survival of patients. Described here is a novel device capable of producing MNB solutions that can be used to preserve viability and function of such organs/tissue. Additionally, these solutions may be used with negative pressure wound therapy to heal soft-tissue wounds.

Safe And Targeted Electric Stimulation Of The Human Cranial Nerves

Neuromodulation (electrical stimulation of the nervous system) is used in cochlear and retinal implants, or deep brain stimulation devices to treat various neurological disorders (i.e. depression, Parkinson’s Disease). However, such approaches tend to be invasive and expensive. Researchers at UCI have developed a novel approach and device to stimulate the cranial nerves that is targeted, safe, and minimally-invasive for the treatment of diseases or the activation of senses.

Visual Field Point-Wise Analyzer

UCLA researchers have developed a novel algorithm to track and predict the progression of patients with glaucoma.

Dry-Eye Formulation

The sensation of ocular discomfort commonly referred to as “dry eye” can be caused by various factors. The principal causative factors are (a) increased tear-evaporation rates attributable to meibomian gland dysfunction and insufficient/unbalanced tear-lipid films; (b) inadequate tear-aqueous production attributable to aging, medical procedures performed on the cornea (e.g., LASIK), or other general health conditions (e.g., autoimmune diseases); (c) environmental irritants (e.g., dust, smoke, wind, sun, or low humidity); and (d) eye strain attributable to extended viewing of computer monitors or other working environment-related factors. There are many different artificial-eye drops marketed and prescribed or recommended by medical practitioners to decrease dry-eye sensations. Unfortunately, all provide only short-term or no effects at all on tear-film stability and evaporation rates. Moreover, many artificial-tear formulations contain petrochemicals, (e.g., mineral oil) which have nothing in common with natural lipids comprising human tear-lipid films and might be potentially harmful to the eye.   Researchers at UC Berkeley have developed bicontinuous microemulsion formulations capable of delivering the components necessary to counteract compromised stability of tear-lipid layers and thus enhance the stability of entire tear films. These bicontinuous microemulsion components disperse spontaneously into a physical state that makes the microemulsion completely miscible with both human tear aqueous and human tear lipids. The components of these microemulsions are chemically identical or very close to natural tear lipids and tear aqueous and thus are completely biocompatible with human tear films. The lipids used in this formulation are biodegradable, and human tear enzymes will be able to metabolize these bicontinuous microemulsion lipids.  

  • Go to Page: